$67M
1-10
Aqualung Therapeutics is creating a groundbreaking monoclonal antibody treatment for severe inflammation. Their innovative approach targets uncontrolled inflammation to help improve patient outcomes.
National Rank
Share
Loading...
In United States
out of startups
Regional Rank
Share
Loading...
In North America
out of startups
City Rank
Share
Loading...
In Tucson
out of startups
National Rank
Share
Loading...
In United States
out of startups
Regional Rank
Share
Loading...
In North America
out of startups
City Rank
Share
Loading...
In Tucson
out of startups
National Rank
Share
Loading...
In United States
out of startups
Regional Rank
Share
Loading...
In North America
out of startups
rankings by:
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...